472 related articles for article (PubMed ID: 17459469)
21. Dendritic poly(L-lysine)-b-Poly(L-lactide)-b-dendritic poly(L-lysine) amphiphilic gene delivery vectors: roles of PLL dendritic generation and enhanced transgene efficacies via termini modification.
Li Y; Zhu Y; Xia K; Sheng R; Jia L; Hou X; Xu Y; Cao A
Biomacromolecules; 2009 Aug; 10(8):2284-93. PubMed ID: 19586045
[TBL] [Abstract][Full Text] [Related]
22. Novel symmetric amphiphilic dendritic poly(L-lysine)-b-poly(L-lactide)-b-dendritic poly(L-lysine) with high plasmid DNA binding affinity as a biodegradable gene carrier.
Li Y; Cui L; Li Q; Jia L; Xu Y; Fang Q; Cao A
Biomacromolecules; 2007 May; 8(5):1409-16. PubMed ID: 17458996
[TBL] [Abstract][Full Text] [Related]
23. Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro.
Yellepeddi VK; Kumar A; Palakurthi S
Anticancer Res; 2009 Aug; 29(8):2933-43. PubMed ID: 19661298
[TBL] [Abstract][Full Text] [Related]
24. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
Mishra V; Jain NK
Int J Pharm; 2014 Jan; 461(1-2):380-90. PubMed ID: 24291772
[TBL] [Abstract][Full Text] [Related]
25. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
[TBL] [Abstract][Full Text] [Related]
26. Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery.
Chandrasekar D; Sistla R; Ahmad FJ; Khar RK; Diwan PV
J Biomed Mater Res A; 2007 Jul; 82(1):92-103. PubMed ID: 17269145
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.
Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L
Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123
[TBL] [Abstract][Full Text] [Related]
28. Giant dendritic molecular electrochrome batteries with ferrocenyl and pentamethylferrocenyl termini.
Ornelas C; Ruiz J; Belin C; Astruc D
J Am Chem Soc; 2009 Jan; 131(2):590-601. PubMed ID: 19113856
[TBL] [Abstract][Full Text] [Related]
29. Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats.
Boyd BJ; Kaminskas LM; Karellas P; Krippner G; Lessene R; Porter CJ
Mol Pharm; 2006; 3(5):614-27. PubMed ID: 17009860
[TBL] [Abstract][Full Text] [Related]
30. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
Patri AK; Kukowska-Latallo JF; Baker JR
Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
[TBL] [Abstract][Full Text] [Related]
31. Encapsulation and stabilization of gold nanoparticles with "click" polyethyleneglycol dendrimers.
Boisselier E; Diallo AK; Salmon L; Ornelas C; Ruiz J; Astruc D
J Am Chem Soc; 2010 Mar; 132(8):2729-42. PubMed ID: 20131826
[TBL] [Abstract][Full Text] [Related]
32. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.
Zhang XQ; Intra J; Salem AK
Bioconjug Chem; 2007; 18(6):2068-76. PubMed ID: 17848077
[TBL] [Abstract][Full Text] [Related]
33. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery.
Patil ML; Zhang M; Betigeri S; Taratula O; He H; Minko T
Bioconjug Chem; 2008 Jul; 19(7):1396-403. PubMed ID: 18576676
[TBL] [Abstract][Full Text] [Related]
34. In vivo toxicity of poly(propyleneimine) dendrimers.
Ziemba B; Janaszewska A; Ciepluch K; Krotewicz M; Fogel WA; Appelhans D; Voit B; Bryszewska M; Klajnert B
J Biomed Mater Res A; 2011 Nov; 99(2):261-8. PubMed ID: 21976451
[TBL] [Abstract][Full Text] [Related]
35. Use of poly(vinyl alcohol)-coated capillaries for separation of amino-terminated polyamidoamine dendrimers.
Carter B; Desai A; Sharma A
Electrophoresis; 2007 Feb; 28(3):335-40. PubMed ID: 17191277
[TBL] [Abstract][Full Text] [Related]
36. Convenient synthesis and properties of polypropyleneimine dendrimer-functionalized polymer nanoparticles.
Larpent C; Cannizzo C; Delgado A; Gouanvé F; Sanghvi P; Gaillard C; Bacquet G
Small; 2008 Jun; 4(6):833-40. PubMed ID: 18528853
[TBL] [Abstract][Full Text] [Related]
37. Performance evaluation of PAMAM dendrimer based simvastatin formulations.
Kulhari H; Pooja D; Prajapati SK; Chauhan AS
Int J Pharm; 2011 Feb; 405(1-2):203-9. PubMed ID: 21145960
[TBL] [Abstract][Full Text] [Related]
38. Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers.
Birdhariya B; Kesharwani P; Jain NK
Drug Dev Ind Pharm; 2015; 41(8):1393-9. PubMed ID: 25163759
[TBL] [Abstract][Full Text] [Related]
39. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
Tomalia DA; Reyna LA; Svenson S
Biochem Soc Trans; 2007 Feb; 35(Pt 1):61-7. PubMed ID: 17233602
[TBL] [Abstract][Full Text] [Related]
40. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers.
Kaminskas LM; Boyd BJ; Karellas P; Krippner GY; Lessene R; Kelly B; Porter CJ
Mol Pharm; 2008; 5(3):449-63. PubMed ID: 18393438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
